Investigating the toxic effects induced by iron oxide nanoparticles on neuroblastoma cell line: an integrative study combining cytotoxic, genotoxic and proteomic tools.


Journal

Nanotoxicology
ISSN: 1743-5404
Titre abrégé: Nanotoxicology
Pays: England
ID NLM: 101233132

Informations de publication

Date de publication:
10 2019
Historique:
pubmed: 28 5 2019
medline: 21 4 2020
entrez: 29 5 2019
Statut: ppublish

Résumé

Nanomaterials have gained much attention for their use and benefit in several fields. Iron Oxide Nanoparticles (IONPs) have been used in Biomedicine as contrast agents for imaging cancer cells. However, several studies reported the potential toxicity of those nanoparticles in different models, especially in cells. Therefore, in our present study, we investigated the effects of IONPs on the SH-SY5Y neuroblastoma cell line. We carried out cytotoxic and genotoxic studies to evaluate the phenotypic effects, and proteomic investigation to evaluate the molecular effects and the mechanisms by which this kind of NPs could induce toxicity. Our results showed that the use of three different sizes of IONPs (14, 22 and 30 nm) induced cell detachment, cell morphological changes, size, and concentration-dependent IONP internalization and cell mortality. IONPs induced slight genotoxic damage assayed by modified comet assay without affecting cell cycle, mitochondrial function, membrane integrity, intracellular calcium level, and without inducing ROS generation. All the studies were performed to compare also the effects of IONPs to the ferric iron by incubating cells with equivalent concentration of FeCl

Identifiants

pubmed: 31132913
doi: 10.1080/17435390.2019.1621399
doi:

Substances chimiques

Ferric Compounds 0
Proteome 0
Reactive Oxygen Species 0
ferric oxide 1K09F3G675

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1021-1040

Auteurs

Dalel Askri (D)

PROMETHEE Proteomic Platform, BEeSy, Grenoble Alpes University , Grenoble , France.
LBFA Inserm U1055, PROMETHEE Proteomic Platform , Grenoble , France.
CHU de Grenoble Alpes, Institut de Biologie et Pathologie , Grenoble, France.
Unit of Research in Integrated Physiology, College of Sciences of Bizerte, Carthage University , Bizerte , Tunisia.

Valérie Cunin (V)

PROMETHEE Proteomic Platform, BEeSy, Grenoble Alpes University , Grenoble , France.
LBFA Inserm U1055, PROMETHEE Proteomic Platform , Grenoble , France.
CHU de Grenoble Alpes, Institut de Biologie et Pathologie , Grenoble, France.

David Béal (D)

SyMMES/CIBEST UMR 5819 UGA-CNRS-CEA, INAC/CEA-Grenoble LAN, University Grenoble Alpes , Grenoble , France.

Sylvie Berthier (S)

Cytometry Platform, Pole Biology, University Grenoble Alpes , Grenoble , France.

Benoit Chovelon (B)

CHU de Grenoble Alpes, Institut de Biologie et Pathologie , Grenoble, France.
DPM UMR 5063, University Grenoble Alpes , Grenoble , France.

Josiane Arnaud (J)

LBFA Inserm U1055, PROMETHEE Proteomic Platform , Grenoble , France.
CHU de Grenoble Alpes, Institut de Biologie et Pathologie , Grenoble, France.

Walid Rachidi (W)

SyMMES/CIBEST UMR 5819 UGA-CNRS-CEA, INAC/CEA-Grenoble LAN, University Grenoble Alpes , Grenoble , France.

Mohsen Sakly (M)

Unit of Research in Integrated Physiology, College of Sciences of Bizerte, Carthage University , Bizerte , Tunisia.

Salem Amara (S)

Unit of Research in Integrated Physiology, College of Sciences of Bizerte, Carthage University , Bizerte , Tunisia.

Michel Sève (M)

PROMETHEE Proteomic Platform, BEeSy, Grenoble Alpes University , Grenoble , France.
LBFA Inserm U1055, PROMETHEE Proteomic Platform , Grenoble , France.
CHU de Grenoble Alpes, Institut de Biologie et Pathologie , Grenoble, France.

Sylvia G Lehmann (SG)

PROMETHEE Proteomic Platform, BEeSy, Grenoble Alpes University , Grenoble , France.
LBFA Inserm U1055, PROMETHEE Proteomic Platform , Grenoble , France.
CHU de Grenoble Alpes, Institut de Biologie et Pathologie , Grenoble, France.
CNRS, IRD, IFSTTAR, ISTerre, University Grenoble Alpes , Grenoble , France.
CNRS, IRD, IFSTTAR, ISTerre, University Savoie Mont Blanc , Grenoble , France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH